LKB1 Modulates Lung Cancer Differentiation and Metastasis.
Hongbin Ji,Matthew R. Ramsey,D. Neil Hayes,Cheng Fan,Kate McNamara,Piotr Kozlowski,Chad Torrice,Michael C. Wu,Takeshi Shimamura,Samanthi A. Perera,Mei-Chih Liang,Dongpo Cai,George N. Naumov,Lei Bao,Cristina M. Contreras,Danan Li,Liang Chen,Janakiraman Krishnamurthy,Jussi Koivunen,Lucian R. Chirieac,Robert F. Padera,Roderick T. Bronson,Neal I. Lindeman,David C. Christiani,Xihong Lin,Geoffrey I. Shapiro,Pasi A. Jänne,Bruce E. Johnson,Matthew Meyerson,David J. Kwiatkowski,Diego H. Castrillon,Nabeel Bardeesy,Norman E. Sharpless,Kwok-Kin Wong
DOI: https://doi.org/10.1038/nature06030
IF: 64.8
2007-01-01
Nature
Abstract:Lkb1 and cancer causation Mutations in the Lkb1 tumour suppressor gene are found in Peutz–Jeghers syndrome patients who have an increased incidence of cancers. Now Lkb1 mutations have been found in the squamous carcinoma subtype of non-small-cell lung cancers. In a mouse model for lung cancer in which Lkb1 loss is combined with K-Ras mutations, more aggressive tumours arise than with K-Ras mutations alone and often these are classified as squamous and large-cell carcinomas. Thus loss of Lkb1 modulates lung cancer differentiation, and Lkb1 loss may be a useful marker for predicting disease development and spread. The pathways regulated by LKB1 represent possible therapeutic targets.